Feb. 29, 2024

The American College of Radiology® (ACR®) Committee on Drugs and Contrast Media this week released a revised contrast statement that provides flexibility to facilities for contrast studies while maintaining patient safety.

If a physician provides direct supervision for the study — on-site or remotely — the revised statement makes clear a medical professional trained to manage contrast reactions should be on-site.

Healthcare providers with the capabilities specified in the contrast statement can provide the service on-site, as long as those qualifications and the process are consistent with state and local laws and policies, as well as the process and policies of the service site.


Related ACR News

  • ACR Highlights Imaging Payment Changes in HOPPS Final Rule

    ACR outlines key radiology updates in CMS 2026 HOPPS final rule, including payment changes and quality reporting updates effective Jan. 1.

    Read more
  • ACR Provides Input to FDA on AI Measurement and Evaluation

    ACR submitted comments to FDA on real-world AI device performance, stressing safety, governance, and continuous monitoring.

    Read more
  • Radiology’s Fight Against Prior Authorization Delays

    ACR is leading national efforts to make prior authorization more efficient and clinically appropriate while reducing the administrative burden and supporting national legislation.

    Read more